Finanical Statements
Memphis Pharmaceuticals (MPCI.CA) Reports its Financial Results for the Period from 01/07/2025 to 31/03/2026
Published at 24 May 2026 at 09:25Memphis PharmaceuticalsRelated stock:Memphis Pharmaceuticals stockAll Memphis Pharmaceuticals disclosures
Disclosure summary
Company Name: Memphis Pharmaceuticals
ISIN Code: EGS38351C010
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 31/03/2026
Net profit: 388,758,240
F/S Period: From 01/07/2024 to 31/03/2025
Net Comparative profit: 375,756,321
Audit Status: Reviewed
The Financial Statements (4,073 KB)
ISIN Code: EGS38351C010
Currency: Egyptian Pound
F/S Period: From 01/07/2025 to 31/03/2026
Net profit: 388,758,240
F/S Period: From 01/07/2024 to 31/03/2025
Net Comparative profit: 375,756,321
Audit Status: Reviewed
The Financial Statements (4,073 KB)